- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有29家主力机构披露2025-06-30报告期持股数据，持仓量总计8236.02万股，占流通A股6.74%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了41%的股票
技术面评分前10的股票
近期的平均成本为11.22元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为11.22元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.22","date":1756368456,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2025.08.29","stock":"0.00","trade":"1.06","ind":"0.99"},{"date":"2025.08.28","stock":"0.72","trade":"-0.40","ind":"2.25"},{"date":"2025.08.27","stock":"-5.59","trade":"-2.79","ind":"-1.43"},{"date":"2025.08.26","stock":"-0.25","trade":"-0.99","ind":"0.26"},{"date":"2025.08.25","stock":"2.07","trade":"1.41","ind":"2.26"},{"date":"2025.08.22","stock":"-0.26","trade":"-0.02","ind":"2.07"},{"date":"2025.08.21","stock":"-1.02","trade":"0.11","ind":"-0.06"},{"date":"2025.08.20","stock":"-1.76","trade":"-0.61","ind":"0.89"},{"date":"2025.08.19","stock":"1.19","trade":"0.81","ind":"-0.12"},{"date":"2025.08.18","stock":"0.51","trade":"1.68","ind":"1.73"},{"date":"2025.08.15","stock":"1.21","trade":"1.22","ind":"1.60"},{"date":"2025.08.14","stock":"-2.35","trade":"-1.28","ind":"-0.87"},{"date":"2025.08.13","stock":"-1.00","trade":"2.24","ind":"1.76"},{"date":"2025.08.12","stock":"-2.36","trade":"-0.91","ind":"0.53"},{"date":"2025.08.11","stock":"10.41","trade":"1.39","ind":"1.46"},{"date":"2025.08.08","stock":"1.92","trade":"0.26","ind":"-0.26"},{"date":"2025.08.07","stock":"-1.44","trade":"-1.51","ind":"-0.18"},{"date":"2025.08.06","stock":"-3.82","trade":"-0.95","ind":"0.64"},{"date":"2025.08.05","stock":"-2.12","trade":"-0.24","ind":"0.59"},{"date":"2025.08.04","stock":"-1.01","trade":"1.49","ind":"0.46"},{"date":"2025.08.01","stock":"-1.73","trade":"0.18","ind":"-0.17"}]
安科生物,深证成指,生物制品指数
压力支撑
该股压力位为11.19元，支撑位为11.07元。
[{"text":"\u538b\u529b\u4f4d","value":"11.19","date":1756396800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.07","date":1756396800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.4资金面打败了0%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：08月29日 20:30
| 机构今日流向(万元) | -713.78 | 机构5日流向(万元) | -12703.03 |
| 机构10日流向(万元) | -19191.80 | 机构20日流向(万元) | -37210.34 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少7142.36万股，其中基金净减仓8家，主力净减仓147家，请投资者中长期谨慎为宜。
截止2025-06-30，共29家主力机构（基金27家，一般法人2家），持仓量总计8236.02万股，占流通A股6.74%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：8家 ，减持 457.64万股
新出现在主力名单中：20家 ，持有3155.74万股
从主力名单中消失：167家 ，原持有10571.07万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：8家 ，减持 457.64万股
新出现在主力名单中：20家 ，持有3155.74万股
从主力名单中消失：167家 ，原持有10571.07万股
消息面诊股
诊断结果：5.8消息面打败了26%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 安科生物：8月27日获融资买入1.43亿元
2025-08-28 - 【华安医药】公司点评安科生物：BD合作协同共赢，布
2025-08-27 - 国内首款治疗不孕不育长效注射液获批
2025-08-27 - 机构评级|华安证券给予安科生物“买入”评级 未给出
2025-08-27 - 安科生物：8月26日获融资买入1.73亿元
2025-08-27 - 九典制药、安科生物、特宝生物等多家药企迎来机构扎堆
2025-08-26 - 安科生物：8月25日获融资买入1.07亿元，占当日
2025-08-26 - 国内首款长效重组人卵泡刺激素获批上市
2025-08-26 - 安科生物代理国内首款长效FSH-CTP获批上市
2025-08-25 - 国内首款长效重组人卵泡刺激素获批上市 安科生物携手
2025-08-25
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-07-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-03-28 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 利好 | 分红转增 | 10派1元(含税) | 2024-12-20 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.1行业面打败了74%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.08.29","price":"0.99","value":"1.06"},{"date":"2025.08.28","price":"2.25","value":"-0.40"},{"date":"2025.08.27","price":"-1.43","value":"-2.79"},{"date":"2025.08.26","price":"0.26","value":"-0.99"},{"date":"2025.08.25","price":"2.26","value":"1.41"},{"date":"2025.08.22","price":"2.07","value":"-0.02"},{"date":"2025.08.21","price":"-0.06","value":"0.11"},{"date":"2025.08.20","price":"0.89","value":"-0.61"},{"date":"2025.08.19","price":"-0.12","value":"0.81"},{"date":"2025.08.18","price":"1.73","value":"1.68"},{"date":"2025.08.15","price":"1.60","value":"1.22"},{"date":"2025.08.14","price":"-0.87","value":"-1.28"},{"date":"2025.08.13","price":"1.76","value":"2.24"},{"date":"2025.08.12","price":"0.53","value":"-0.91"},{"date":"2025.08.11","price":"1.46","value":"1.39"},{"date":"2025.08.08","price":"-0.26","value":"0.26"},{"date":"2025.08.07","price":"-0.18","value":"-1.51"},{"date":"2025.08.06","price":"0.64","value":"-0.95"},{"date":"2025.08.05","price":"0.59","value":"-0.24"},{"date":"2025.08.04","price":"0.46","value":"1.49"},{"date":"2025.08.01","price":"-0.17","value":"0.18"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 荣昌生物 | 44.97% | 15.14% | 6.8分 |
| 2 | 欧林生物 | 36.79% | -10.22% | 6.7分 |
| 3 | 迈威生物 | 30.93% | 22.39% | 5.7分 |
| 4 | 我武生物 | 25.60% | 14.79% | 6.4分 |
| 5 | 甘李药业 | 19.58% | 6.39% | 6.6分 |
| 6 | 君实生物 | 18.15% | -1.90% | 6.0分 |
| 8 | 西藏药业 | 12.31% | 2.43% | 6.0分 |
| 10 | 艾迪药业 | 8.57% | 0.93% | 6.2分 |
| 12 | 康泰生物 | 6.37% | 1.41% | 5.2分 |
| 14 | 康希诺 | 3.30% | -5.84% | 4.9分 |
| 16 | 百奥泰 | 2.26% | -2.43% | 5.9分 |
| 18 | 义翘神州 | 1.80% | 0.99% | 5.7分 |
| 20 | 赛伦生物 | 0.61% | -2.46% | 4.8分 |
| 22 | 通化东宝 | 0.24% | -0.59% | 5.5分 |
| 24 | 上海莱士 | -0.43% | -1.57% | 5.1分 |
| 26 | 成大生物 | -1.73% | -4.06% | 4.9分 |
| 28 | 诺诚健华 | -2.25% | -5.50% | 4.6分 |
| 30 | 诺唯赞 | -2.52% | -5.97% | 5.3分 |
| 32 | 智翔金泰 | -2.65% | -1.23% | 4.9分 |
| 34 | 卫光生物 | -3.59% | -2.87% | 5.2分 |
| 36 | 康华生物 | -5.15% | -11.14% | 4.7分 |
| 38 | 智飞生物 | -5.62% | -2.81% | 4.4分 |
| 40 | 安科生物 | -5.71% | -3.19% | 5.0分 |
| 42 | 东宝生物 | -6.85% | -4.52% | 4.9分 |
| 44 | 凯因科技 | -7.62% | -10.19% | 5.5分 |
| 46 | 博晖创新 | -8.51% | -7.37% | 4.9分 |
| 48 | 赛升药业 | -10.77% | -7.64% | 4.1分 |
| 50 | 康辰药业 | -11.46% | 6.28% | 5.8分 |
| 52 | 科兴制药 | -20.03% | -0.40% | 5.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/72 ， 19/72。
[{"date":"2025-06-30","value":"9.06","vol":"0.63"},{"date":"2025-03-31","value":"5.09","vol":"0.63"},{"date":"2024-12-31","value":"17.98","vol":"-0.24"},{"date":"2024-09-30","value":"15.37","vol":"1.37"},{"date":"2024-06-30","value":"11.12","vol":"0.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.06 | 5.09 | 17.98 | 15.37 | 11.12 |
| 行业(%) | 0.63 | 0.63 | -0.24 | 1.37 | 0.72 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"76.45","vol":"69.88"},{"date":"2025-03-31","value":"76.96","vol":"69.78"},{"date":"2024-12-31","value":"77.39","vol":"69.97"},{"date":"2024-09-30","value":"77.75","vol":"70.57"},{"date":"2024-06-30","value":"78.25","vol":"69.89"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
76.45 | 76.96 | 77.39 | 77.75 | 78.25 |
| 行业(%) | 69.88 | 69.78 | 69.97 | 70.57 | 69.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 28/72 ， 27/72。
[{"date":"2025-06-30","value":"-0.51","vol":"11.89"},{"date":"2025-03-31","value":"-4.17","vol":"6246.12"},{"date":"2024-12-31","value":"-11.51","vol":"48.20"},{"date":"2024-09-30","value":"-4.95","vol":"178.44"},{"date":"2024-06-30","value":"0.90","vol":"19.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.51 | -4.17 | -11.51 | -4.95 | 0.90 |
| 行业(%) | 11.89 | 6246.12 | 48.20 | 178.44 | 19.75 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-11.92","vol":"9.37"},{"date":"2025-03-31","value":"-4.02","vol":"-7.36"},{"date":"2024-12-31","value":"-16.56","vol":"-10.38"},{"date":"2024-09-30","value":"-9.89","vol":"-53.42"},{"date":"2024-06-30","value":"4.99","vol":"-9.25"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-11.92 | -4.02 | -16.56 | -9.89 | 4.99 |
| 行业(%) | 9.37 | -7.36 | -10.38 | -53.42 | -9.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/72 ， 5/72。
[{"date":"2025-06-30","value":"0.26","vol":"0.15"},{"date":"2025-03-31","value":"0.12","vol":"0.06"},{"date":"2024-12-31","value":"0.50","vol":"0.29"},{"date":"2024-09-30","value":"0.39","vol":"0.22"},{"date":"2024-06-30","value":"0.27","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.26 | 0.12 | 0.50 | 0.39 | 0.27 |
| 行业(次) | 0.15 | 0.06 | 0.29 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.05","vol":"0.56"},{"date":"2025-03-31","value":"0.49","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.19"},{"date":"2024-09-30","value":"1.58","vol":"0.87"},{"date":"2024-06-30","value":"1.04","vol":"0.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.05 | 0.49 | 2.15 | 1.58 | 1.04 |
| 行业(次) | 0.56 | 0.26 | 1.19 | 0.87 | 0.55 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/72 ， 7/72。
[{"date":"2025-06-30","value":"18.27","vol":"-1660.76"},{"date":"2025-03-31","value":"31.05","vol":"-47.52"},{"date":"2024-12-31","value":"43.02","vol":"-9.01"},{"date":"2024-09-30","value":"34.56","vol":"-29.47"},{"date":"2024-06-30","value":"7.95","vol":"-36875.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.27 | 31.05 | 43.02 | 34.56 | 7.95 |
| 行业 | -1660.76 | -47.52 | -9.01 | -29.47 | -36875.39 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.52","vol":"1.48"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.94","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.17","vol":"2.72"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.52 | - | 0.94 | - | 1.17 |
| 行业 | 1.48 | 0.00 | 2.00 | 0.00 | 2.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 19/72 ， 19/72。
[{"date":"2025-06-30","value":"3.36","vol":"7.27"},{"date":"2025-03-31","value":"3.07","vol":"7.90"},{"date":"2024-12-31","value":"3.41","vol":"6.83"},{"date":"2024-09-30","value":"3.20","vol":"7.16"},{"date":"2024-06-30","value":"2.92","vol":"7.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.36 | 3.07 | 3.41 | 3.20 | 2.92 |
| 行业 | 7.27 | 7.90 | 6.83 | 7.16 | 7.04 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.63","vol":"5.94"},{"date":"2025-03-31","value":"2.61","vol":"6.47"},{"date":"2024-12-31","value":"2.95","vol":"5.50"},{"date":"2024-09-30","value":"2.70","vol":"5.77"},{"date":"2024-06-30","value":"2.45","vol":"5.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.63 | 2.61 | 2.95 | 2.70 | 2.45 |
| 行业 | 5.94 | 6.47 | 5.50 | 5.77 | 5.91 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/72 ， 22/72。
[{"date":"2025-06-30","value":"15.83","vol":"25.25"},{"date":"2025-03-31","value":"16.52","vol":"25.48"},{"date":"2024-12-31","value":"16.27","vol":"25.46"},{"date":"2024-09-30","value":"17.20","vol":"24.92"},{"date":"2024-06-30","value":"18.46","vol":"24.62"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
15.83 | 16.52 | 16.27 | 17.20 | 18.46 |
| 行业(%) | 25.25 | 25.48 | 25.46 | 24.92 | 24.62 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.20","vol":"1.16"},{"date":"2025-03-31","value":"0.21","vol":"0.78"},{"date":"2024-12-31","value":"0.20","vol":"0.88"},{"date":"2024-09-30","value":"0.22","vol":"0.41"},{"date":"2024-06-30","value":"0.24","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.20 | 0.21 | 0.20 | 0.22 | 0.24 |
| 行业(%) | 1.16 | 0.78 | 0.88 | 0.41 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.07","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.86","blueLineValue":"0.47","type":"YC"}]